Inhibitors of lactate dehydrogenase, compositions comprising the inhibitor, and methods of use thereof

WO2025242056A1PCT designated stage Publication Date: 2025-11-27META PHARM (HK) LTD +1

Patent Information

Application Number
PCT/CN2025/095853
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-20
Filing Date
2025-05-19
Publication Date
2025-11-27

Smart Images

  • Figure PCTCN2025095853-FTAPPB-I100001
    Figure PCTCN2025095853-FTAPPB-I100001
  • Figure PCTCN2025095853-FTAPPB-I100002
    Figure PCTCN2025095853-FTAPPB-I100002
  • Figure PCTCN2025095853-FTAPPB-I100003
    Figure PCTCN2025095853-FTAPPB-I100003
Patent Text Reader

Abstract

The present disclosure provides novel substituted pyrrole compounds that can serve as inhibitors of lactate dehydrogenase, pharmaceutical compositions, comprising at least one of such novel substituted pyrrole compounds, and methods of using at least one of such compounds or compositions in treating or preventing diseases associated with lactate dehydrogenase activities, such as primary hyperoxaluria.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    WO2016109559A2

  • 1 h-pyrazol-1 -YL-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof

    WO2018005807A1

  • Substituted pyrazolyl compounds and methods of use thereof

    WO2021234543A1

  • Substituted pyrazolyl compounds and methods of use thereof

    WO2021234547A1

Cited By

  • PROTAC compound targeting lactic dehydrogenase as well as preparation method and application of PROTAC compound

    CN122234044A